CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $39,000 | +39.3% | 2,148 | 0.0% | 0.01% | +42.9% |
| Q3 2014 | $28,000 | -20.0% | 2,148 | 0.0% | 0.01% | -22.2% |
| Q2 2014 | $35,000 | -7.9% | 2,148 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $38,000 | -26.9% | 2,148 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $52,000 | -30.7% | 2,148 | 0.0% | 0.01% | -20.0% |
| Q3 2013 | $75,000 | – | 2,148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |